Indaptus Therapeutics Inc

NASDAQ:INDP   3:59:59 PM EDT
2.90
+0.40 (+16.00%)
4:29:54 PM EDT: $2.86 -0.04 (-1.38%)
Earnings Announcements

Indaptus Therapeutics Reports Q4 Results

Published: 03/21/2022 12:37 GMT
Indaptus Therapeutics Inc (INDP) - Indaptus Therapeutics Reports Fourth Quarter and Year End 2021 Financial Results and Provides Corporate Update.
Indaptus Therapeutics Inc - As of December 31, 2021, Company Had Cash and Cash Equivalents of Approximately $39.1 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.47

More details on our Analysts Page.